Ann M. Geiger, PhD
Articles
January 13th 2014
Comorbidities and Cardiovascular Disease Risk in Older Breast Cancer Survivors
Reina Haque, PhD, MPH Marianne Prout, MD Ann M. Geiger, PhD Aruna Kamineni, PhD Soe Soe Thwin, PhD Chantal Avila, MA Rebecca A. Silliman, MD, PhD Virginia Quinn, PhD Marianne Ulcickas Yood, DSc
Effective management of the comorbidities of diabetes and hypertension may increase survival in older breast cancer survivors.
November 6th 2009
Delayed Radiotherapy for Breast Cancer Patients in Integrated Delivery Systems
Heather Taffet Gold, PhD Soe Soe Thwin, PhD Diana S. M. Buist, PhD, MPH Terry S. Field, DSc Feifei Wei, PhD Marianne Ulcickas Yood, DSc, MPH Timothy L. Lash, DSc Virginia P. Quinn, PhD Ann M. Geiger, PhD Rebecca A. Silliman, MD, PhD
Among older women in 5 integrated delivery systems, 14% experienced delayed radiotherapy for breast cancer, even though they had insurance and access to care.
July 1st 2005
Organizational Barriers to Physician Participation in Cancer Clinical Trials
Carol P. Somkin, PhD Andrea Altschuler, PhD Lynn Ackerson, PhD Ann M. Geiger, PhD Sarah M. Greene, MPH Judy Mouchawar, MD, MPH Joan Holup, MA Louis Fehrenbacher, MD Andrew Nelson, MPH Andrew Glass, MD Jonathan Polikoff, MD Sigrid Tishler, MD Carolyn Schmidt, RN Terry Field, DSc Edward Wagner, MD, MPH
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: December 17th 2024 | Updated: December 22nd 2024
ICYMI: Highlights From IMS 2024
